[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2023 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-May-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
31-Mar-2023 [#1]
Profit Trend
QoQ- 29.12%
YoY- 11.54%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 704,727 716,301 735,982 801,900 696,717 726,342 735,366 -2.78%
PBT 63,267 74,977 89,610 113,168 84,851 92,672 96,238 -24.33%
Tax -10,622 -16,120 -19,266 -22,636 -14,739 -22,070 -23,034 -40.22%
NP 52,645 58,857 70,344 90,532 70,112 70,601 73,204 -19.68%
-
NP to SH 52,645 58,857 70,344 90,532 70,112 70,601 73,204 -19.68%
-
Tax Rate 16.79% 21.50% 21.50% 20.00% 17.37% 23.82% 23.93% -
Total Cost 652,082 657,444 665,638 711,368 626,605 655,741 662,162 -1.01%
-
Net Worth 682,979 673,359 670,448 666,567 657,045 647,522 634,375 5.03%
Dividend
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Div 22,124 6,412 9,577 - 21,901 6,348 9,468 75.81%
Div Payout % 42.03% 10.90% 13.62% - 31.24% 8.99% 12.93% -
Equity
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Net Worth 682,979 673,359 670,448 666,567 657,045 647,522 634,375 5.03%
NOSH 961,942 961,942 961,942 952,239 952,239 952,239 952,239 0.67%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 7.47% 8.22% 9.56% 11.29% 10.06% 9.72% 9.95% -
ROE 7.71% 8.74% 10.49% 13.58% 10.67% 10.90% 11.54% -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 73.26 74.46 76.84 84.21 73.17 76.28 77.67 -3.81%
EPS 5.49 6.15 7.36 9.52 7.39 7.45 7.76 -20.55%
DPS 2.30 0.67 1.00 0.00 2.30 0.67 1.00 73.97%
NAPS 0.71 0.70 0.70 0.70 0.69 0.68 0.67 3.93%
Adjusted Per Share Value based on latest NOSH - 952,239
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 73.21 74.41 76.45 83.30 72.37 75.45 76.39 -2.78%
EPS 5.47 6.11 7.31 9.40 7.28 7.33 7.60 -19.63%
DPS 2.30 0.67 0.99 0.00 2.28 0.66 0.98 76.33%
NAPS 0.7095 0.6995 0.6965 0.6924 0.6825 0.6726 0.659 5.03%
Price Multiplier on Financial Quarter End Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 -
Price 1.26 1.20 1.30 1.56 1.61 1.30 1.20 -
P/RPS 1.72 1.61 1.69 1.85 2.20 1.70 1.55 7.16%
P/EPS 23.02 19.61 17.70 16.41 21.87 17.53 15.52 29.96%
EY 4.34 5.10 5.65 6.09 4.57 5.70 6.44 -23.07%
DY 1.83 0.56 0.77 0.00 1.43 0.51 0.83 69.15%
P/NAPS 1.77 1.71 1.86 2.23 2.33 1.91 1.79 -0.74%
Price Multiplier on Announcement Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 22/02/24 08/11/23 24/08/23 22/05/23 23/02/23 09/11/22 16/08/22 -
Price 1.21 1.22 1.19 1.44 1.65 1.39 1.34 -
P/RPS 1.65 1.64 1.55 1.71 2.26 1.82 1.73 -3.09%
P/EPS 22.11 19.94 16.20 15.15 22.41 18.75 17.33 17.58%
EY 4.52 5.02 6.17 6.60 4.46 5.33 5.77 -14.98%
DY 1.90 0.55 0.84 0.00 1.39 0.48 0.75 85.52%
P/NAPS 1.70 1.74 1.70 2.06 2.39 2.04 2.00 -10.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment